###begin article-title 0
###xml 58 63 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Characterization of the Molecular Determinants of Primary HIV-1 Vpr Proteins: Impact of the Q65R and R77Q Substitutions on Vpr Functions
###end article-title 0
###begin p 1
Conceived and designed the experiments: GJ ELR VP LMJ SB. Performed the experiments: GJ ELR PMP MM VD CMF DH. Analyzed the data: GJ ELR PMP VP LMJ SB. Contributed reagents/materials/analysis tools: JJL. Wrote the paper: GJ VP LMJ SB.
###end p 1
###begin p 2
###xml 46 54 46 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 240 243 240 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 9 14 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 406 413 <span type="species:ncbi:9606">patient</span>
Although HIV-1 Vpr displays several functions in vitro, limited information exists concerning their relevance during infection. Here, we characterized Vpr variants isolated from a rapid and a long-term non-progressor (LTNP). Interestingly, vpr alleles isolated from longitudinal samples of the LTNP revealed a dominant sequence that subsequently led to diversity similar to that observed in the progressor patient. Most of primary Vpr proteins accumulated at the nuclear envelope and interacted with host-cell partners of Vpr. They displayed cytostatic and proapoptotic activities, although a LTNP allele, harboring the Q65R substitution, failed to bind the DCAF1 subunit of the Cul4a/DDB1 E3 ligase and was inactive. This Q65R substitution correlated with impairment of Vpr docking at the nuclear envelope, raising the possibility of a functional link between this property and the Vpr cytostatic activity. In contradiction with published results, the R77Q substitution, found in LTNP alleles, did not influence Vpr proapoptotic activity.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 94 101 94 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 151 154 151 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-LeRouzic1">[1]</xref>
###xml 178 181 178 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 535 542 535 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 676 679 676 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 696 699 696 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpx</italic>
###xml 795 798 795 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Gibbs1">[2]</xref>
###xml 800 803 800 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Lang1">[3]</xref>
###xml 43 48 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 172 177 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 284 289 <span type="species:ncbi:9606">human</span>
###xml 327 330 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
###xml 349 354 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 433 441 <span type="species:ncbi:9606">patients</span>
###xml 512 517 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 568 583 <span type="species:ncbi:9544">rhesus macaques</span>
###xml 660 663 <span type="species:ncbi:11723?0.9432672590567327">SIV</span>
Like for other 〈〈 auxiliary 〉〉 proteins of HIV-1, it has been suggested that Vpr is important in vivo for virus replication and pathogenesis (see Ref. [1] for review). The HIV-1 vpr gene encodes a 14 kDa protein and is one of the most highly conserved genes among primary isolates of human and simian immunodeficiency viruses (SIV). Vpr is found in HIV-1 virions, in infected cells, but also in sera and cerebro-spinal fluid of AIDS patients, suggesting that it participates in various aspects of the biology of HIV-1. The role of Vpr in vivo has been investigated in rhesus macaques infected with SIVmac, and it was initially shown that monkeys infected with SIV lacking the vpr and the related vpx genes displayed a lower virus burden and did not consistently develop immunodeficiency disease [2], [3]. Despite these observations, the exact contributions of Vpr during the natural course of infection are still elusive.
###end p 4
###begin p 5
###xml 52 60 52 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 265 268 265 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-LeRouzic1">[1]</xref>
###xml 448 451 448 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Selig1">[4]</xref>
###xml 452 455 452 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Chen1">[6]</xref>
###xml 634 637 634 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Popov1">[7]</xref>
###xml 638 642 638 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Vodicka1">[10]</xref>
###xml 777 781 777 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Vodicka1">[10]</xref>
###xml 783 787 783 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-NitaharaKasahara1">[11]</xref>
###xml 912 916 912 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Belzile1">[12]</xref>
###xml 917 921 917 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Wen1">[17]</xref>
###xml 992 996 992 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Goh1">[18]</xref>
###xml 42 47 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 245 250 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 972 977 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1132 1140 <span type="species:ncbi:9606">patients</span>
Several functions have been attributed to HIV-1 Vpr in vitro, including an effect on the reverse-transcription process, nuclear import of the viral DNA, cell cycle arrest at the G2/M transition, induction of apoptosis and transactivation of the HIV-1 LTR (see Ref. [1] for review). While its role in the reverse transcription process implies interaction with the nuclear form of the DNA repair enzyme UNG2 for modulation of the virus mutation rate [4]-[6], it was suggested that Vpr participates in the DNA nuclear import process through docking to the nuclear envelope (NE) by interaction with components of the nuclear pore complex [7]-[10], such as the nucleoporin hCG1. While these properties of Vpr have been shown to contribute to virus replication in non-dividing cells [10], [11], Vpr-induced G2-arrest, which is consequent to its interaction with the DCAF1 subunit of the Cul4a/DDB1 E3 ubiquitin ligase [12]-[17], may provide a favorable cellular environment for HIV-1 transcription [18]. In addition, the proapoptotic activity of Vpr has been postulated to contribute to the depletion of CD4+ T cells observed in infected patients.
###end p 5
###begin p 6
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-DiMarzio1">[19]</xref>
###xml 123 127 123 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Yao1">[21]</xref>
###xml 317 320 317 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 657 660 657 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 735 739 735 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Lum1">[22]</xref>
###xml 789 793 789 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Mologni1">[23]</xref>
###xml 912 916 912 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Fischer1">[24]</xref>
###xml 917 921 917 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Rajan1">[28]</xref>
###xml 62 67 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 343 348 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 358 366 <span type="species:ncbi:9606">patients</span>
###xml 601 606 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 716 724 <span type="species:ncbi:9606">patients</span>
Although numerous studies have demonstrated that mutations in HIV-1 Vpr could dramatically affect its known functions [19]-[21], these mutations were artificially created and did not represent the profile of naturally occurring mutations throughout the course of infection. While only a few genotypic analyses of the vpr alleles isolated from HIV-1 infected patients have been performed, there is no report regarding the functional characterization of primary Vpr variants during the course of infection. Nevertheless, an initial study has reported that a single substitution at the position Arg77 of HIV-1 Vpr (Arg77Gln) was found in a higher frequency in vpr alleles from long-term non-progressors (LTNPs) than in patients with AIDS [22]. While Mologni et al. confirmed this observation [23], several other groups did not find any association of the R77Q substitution with the prognosis of disease progression [24]-[28].
###end p 6
###begin p 7
###xml 128 136 <span type="species:ncbi:9606">patients</span>
The present study aimed at analyzing the molecular and functional properties of primary Vpr proteins isolated from two infected patients, in terms of binding to its known cellular partners, docking at the NE, cytostatic and proapoptotic activities. In particular, a longitudinal analysis of Vpr variants isolated from a long-term non-progressor (LTNP) was performed.
###end p 7
###begin title 8
Results and Discussion
###end title 8
###begin title 9
###xml 22 25 22 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
Molecular analysis of vpr alleles
###end title 9
###begin p 10
###xml 102 106 102 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 172 175 172 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 250 257 250 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007514-g001">Fig. 1A</xref>
###xml 261 263 261 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pr</italic>
###xml 529 532 529 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 604 607 604 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 647 654 647 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007514-t001">Table 1</xref>
###xml 810 813 810 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 850 857 850 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007514-g001">Fig. 1B</xref>
###xml 1337 1344 1337 1344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007514-g001">Fig. 1A</xref>
###xml 1475 1478 1475 1478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 1542 1545 1542 1545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 1593 1600 1593 1600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007514-g001">Fig. 1B</xref>
###xml 1749 1753 1749 1753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Troyer1">[29]</xref>
###xml 1754 1758 1754 1758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Meier1">[32]</xref>
###xml 57 64 <span type="species:ncbi:9606">patient</span>
###xml 228 235 <span type="species:ncbi:9606">patient</span>
###xml 1066 1073 <span type="species:ncbi:9606">patient</span>
###xml 1620 1625 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Peripheral blood mononuclear cells (PBMCs) from the LTNP patient were sampled in 1986, 1996 and 2004 (i.e. 1, 11 and 19 years after infection) for longitudinal analysis of vpr alleles, and a single PBMC sample from a progressor patient was analyzed (Fig. 1A). Vpr genes were amplified by PCR from the cellular DNA and cloned into a shuttle plasmid for genotypic analysis. DNA sequences from 40 independent clones recovered from two independent PCR were determined for each sample, allowing identification of the most represented vpr alleles from viral quasispecies. The relative frequency of the primary vpr alleles identified is recapitulated in Table 1. The first two samples analyzed from the LTNP, namely LTNP-86 and LTNP-96 (GenBank Accession numbers GU014240 and GU014241, respectively), showed a single vpr sequence sharing 95% a.a. identity (Fig. 1B), that subsequently evolved in a genetic diversity (LTNP-04-1 to -04-5; GenBank Accession numbers GU014242, GU014243, GU014244, GU014245 and GU014246, respectively) similar to that observed in the progressor patient (PR-1, PR-2 and PR-3; GenBank Accession numbers GU014237, GU014238 and GU014239, respectively). Notably, the sequence diversity of the LTNP-04 alleles correlated with an increase of the plasma viral load that paralleled a slight decline of the CD4+ T-cell count (Fig. 1A). This decrease of the CD4+ T-cells was still apparent in recent blood samples from 2005 and 2007, and bulk genotypic analysis of vpr from these samples (LTNP-05 and -07) showed that the LTNP-04-1 vpr sequence was still predominant at those times (Fig. 1B). This increase in HIV-1 diversity might be related to an increase in viral fitness, which in turn is a determining factor in infection progression [29]-[32].
###end p 10
###begin title 11
###xml 28 31 28 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 15 23 <span type="species:ncbi:9606">patients</span>
Description of patients and vpr alleles analyzed in the study.
###end title 11
###begin p 12
###xml 227 231 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Lefrere1">[45]</xref>
###xml 233 237 233 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Lefrere2">[46]</xref>
###xml 535 538 535 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 877 880 877 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lai</italic>
###xml 912 915 912 915 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 1064 1067 1064 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 43 51 <span type="species:ncbi:9606">patients</span>
###xml 68 76 <span type="species:ncbi:9606">patients</span>
###xml 100 105 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 115 122 <span type="species:ncbi:9606">patient</span>
###xml 872 875 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 939 946 <span type="species:ncbi:9606">patient</span>
A) Immunological and viral profiles of the patients analyzed. These patients were selected from the HIV-1-infected patient cohort of the St-Antoine Hospital (Paris), and the samples were collected with written informed consent [45], [46]. The graphs show the time-course evolution of the blood CD4+ T cell counts (green curves) and plasmatic virus load (viral RNA, red curves); the PBMC samples analyzed in the present study are indicated by the blue arrows. B) Alignment of the amino acid sequences derived from DNA sequencing of the vpr alleles cloned from PBMC DNA samples. Excepted for LTNP-05 and LTNP-07 sequences that were obtained by direct sequencing of the bulk PCR fragments amplified from these samples, at least 40 independent clones were sequenced from each other samples. The sequences of the primary Vpr proteins are aligned with respect of the prototypic HIV-1Lai sequence (upper sequence). The vpr alleles from the LNTP (patient 5071) that were selected for subsequent functional analysis are in the box; the R77Q substitution identified in some vpr alleles is indicated in blue, while the Q65R substitution identified in the Vpr LTNP-04-2 is indicated in red.
###end p 12
###begin title 13
###xml 41 42 41 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="nt101">a</xref>
Relative frequency of primary Vpr allelesa.
###end title 13
###begin p 14
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 83 90 83 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007514-g001">Fig. 1A</xref>
vpr genes were amplified by PCR from each PBMC sample (indicated by blue arrows in Fig. 1A), cloned into a shuttle plasmid, and DNA sequences from at least 40 independent clones were determined from each sample.
###end p 14
###begin p 15
###xml 46 53 <span type="species:ncbi:9606">patient</span>
###xml 99 106 <span type="species:ncbi:9606">patient</span>
samples 1986, 1996 and 2004 are from the LTNP patient (5071), and sample PR is from the progressor patient (1200).
###end p 15
###begin p 16
###xml 71 78 71 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007514-g001">Fig. 1B</xref>
Vpr alleles correspond to the primary amino acid sequences reported in Fig. 1B.
###end p 16
###begin p 17
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Lum1">[22]</xref>
###xml 166 170 166 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Mologni1">[23]</xref>
###xml 220 227 220 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007514-g001">Fig. 1B</xref>
###xml 423 427 423 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Belzile1">[12]</xref>
###xml 428 432 428 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Wen1">[17]</xref>
###xml 448 451 448 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 530 537 530 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007514-t001">Table 1</xref>
###xml 653 656 653 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 821 825 821 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Agostini1">[33]</xref>
###xml 827 831 827 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Zhou1">[34]</xref>
###xml 914 918 914 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Schrofelbauer1">[35]</xref>
###xml 696 703 <span type="species:ncbi:9606">patient</span>
Interestingly, vpr alleles from LTNP-86 and LTNP-04 samples all contained a R77Q substitution, previously reported as deleterious for Vpr proapoptotic activity [22], [23], whereas LTNP-96 showed an Arg at this position (Fig. 1B). In addition, Vpr LTNP-04-2 contained the Q65R substitution within the leucine-rich domain of Vpr, recently shown as deleterious for Vpr binding to the DCAF1 subunit of the Cul4a/DDB1 E3 ligase [12]-[17]. However, this vpr allele was found only in a minor virus population of the LTNP-04 PBMC sample (Table 1), and no correlation could be established between this mutation and viral load or CD4+ T-cell count. Regarding the vpr sequences isolated from the progressor patient, PR-2 had a substitution of Ser79 in Gly which is predicted to affect Vpr phosphorylation and its G2-arrest activity [33], [34]. Moreover, PR-3 showed a L64P substitution also described as precluding G2-arrest [35].
###end p 17
###begin p 18
###xml 144 151 <span type="species:ncbi:9606">patient</span>
The LTNP-86, LTNP-96 and two predominant alleles from the 2004 sample (LTNP-04-1 and LTNP-04-2), as well as the three alleles of the progressor patient (PR-1, PR-2 and PR-3), were selected for further functional characterization.
###end p 18
###begin title 19
Subcellular localization of the primary Vpr proteins
###end title 19
###begin p 20
###xml 174 181 174 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007514-g002">Fig. 2A</xref>
###xml 193 196 193 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-LeRouzic1">[1]</xref>
###xml 331 338 331 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007514-g002">Fig. 2B</xref>
###xml 435 438 435 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lai</italic>
###xml 488 495 488 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007514-g002">Fig. 2B</xref>
###xml 708 711 708 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lai</italic>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpr primarily localizes in the nucleus, but also accumulates at the NE where it co-localizes with components of the nuclear pore complex, such as the nucleoporin hCG1 (Fig. 2A) (see Ref. [1] for review). A similar cellular distribution was revealed for the LTNP-86, -96 and -04-1 proteins, when expressed as Vpr-GFP fusions (Fig. 2B). Interestingly, the Vpr LTNP-04-2 protein, containing the Q65R substitution, as well as the VprLai-GFP Q65R mutant, failed to accumulate at the NE (Fig. 2B), indicating that this residue participates in the proper localization of Vpr. When expressed as HA-tagged proteins, these Vpr variants similarly co-distributed in the cytoplasm and the nucleus, whereas wt HA-VprLai was concentrated into the nucleus and at the NE (data not shown). This observation also indicates that the Vpr/DCAF1 interaction might be functionally related to the docking of Vpr at the NE.
###end p 20
###begin title 21
###xml 59 67 <span type="species:ncbi:9606">patients</span>
Cellular localization of Vpr proteins from the LTNP and PR patients.
###end title 21
###begin p 22
###xml 408 416 <span type="species:ncbi:9606">patients</span>
(A) Co-localization of VprLai and hCG1 at the NE. HeLa cells were transiently transfected with vectors for expression of VprLai fused to GPF together with hCG1 fused to the Myc tag. 16 h after transfection, cells were fixed and subcellular distribution of the fusion proteins was analyzed by epifluorescence microscopy. (B) Subcellular distribution of the indicated primary Vpr proteins from the LTNP and PR patients fused to GFP. Cells expressing GFP were used as a control.
###end p 22
###begin p 23
###xml 87 94 87 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007514-t001">Table 1</xref>
###xml 165 172 165 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007514-g002">Fig. 2B</xref>
###xml 48 55 <span type="species:ncbi:9606">patient</span>
Among Vpr proteins isolated from the progressor patient, the minor PR-3 allele (see on Table 1) was found equally distributed between the cytoplasm and the nucleus (Fig. 2B). However, we failed to detect the PR-3 protein in transfected T-cells (see below), suggesting that this variant was rather unstable.
###end p 23
###begin title 24
Interaction of primary variants with cellular partners of Vpr
###end title 24
###begin p 25
###xml 442 448 442 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007514-g003">Fig. 3</xref>
###xml 623 626 623 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Selig1">[4]</xref>
###xml 628 631 628 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Mansky1">[5]</xref>
###xml 633 637 633 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Schrofelbauer1">[35]</xref>
###xml 845 849 845 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-DeHart1">[13]</xref>
###xml 851 855 851 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-LeRouzic3">[15]</xref>
###xml 955 958 955 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lai</italic>
###xml 966 969 966 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lai</italic>
###xml 1062 1068 1062 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007514-g003">Fig. 3</xref>
###xml 194 199 <span type="species:ncbi:4932">yeast</span>
###xml 291 299 <span type="species:ncbi:9606">patients</span>
###xml 389 394 <span type="species:ncbi:4932">yeast</span>
###xml 1179 1184 <span type="species:ncbi:4932">yeast</span>
Vpr properties have been related to its ability to interact with host cell partners, including the nucleoporin hCG1, the UNG2 enzyme and DCAF1. These cellular proteins were thus analyzed in the yeast two-hybrid system for interaction with primary Vpr variants isolated from both LTNP and PR patients. Most of the variants did interact with hCG1, UNG2 and DCAF1, as visualized by growth of yeast-transformed cells on medium without histidine (Fig. 3), arguing for a good conservation of the structural determinants required for Vpr functions. While no variant had substitution of the Trp54 residue required for UNG2 binding [4], [5], [35], LTNP-04-2 naturally contained the Q65R substitution and failed to interact with DCAF1, confirming the crucial role of this residue in mediating Vpr/DCAF1 interaction in the context of a primary Vpr variant [13], [15]. It is noteworthy that the residue 77 had no impact on Vpr binding to hCG1, UNG2 or DCAF1. Like VprLai and VprLai-R77Q, primary Vpr proteins with an Arg or a Gln similarly bound to these cellular proteins (Fig. 3). Finally, the negative results obtained with the PR-3 variant suggested that it was also poorly expressed in yeast cells.
###end p 25
###begin title 26
###xml 53 61 <span type="species:ncbi:9606">patients</span>
###xml 95 100 <span type="species:ncbi:4932">yeast</span>
Interaction of the Vpr proteins from the LTNP and PR patients with hCG1, UNG2 and DCAF1 in the yeast two-hybrid system.
###end title 26
###begin p 27
###xml 44 47 44 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lai</italic>
###xml 17 22 <span type="species:ncbi:4932">yeast</span>
###xml 107 115 <span type="species:ncbi:9606">patients</span>
The L40 reporter yeast strain expressing VprLai or the indicated primary Vpr proteins from the LTNP and PR patients fused to LexA (LexA hybrid), in combination with either hCG1, UNG2 or DCAF1 fused to the Gal4 activation domain (Gal4AD hybrid), was analyzed for histidine auxotrophy. Growth in the absence of histidine indicates interaction between hybrid proteins.
###end p 27
###begin title 28
G2-arrest and cell death induction of Vpr variants
###end title 28
###begin p 29
###xml 92 100 92 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 119 122 119 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-LeRouzic1">[1]</xref>
###xml 124 128 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Andersen1">[36]</xref>
###xml 196 202 196 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007514-g004">Fig. 4</xref>
###xml 247 251 247 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Andersen2">[37]</xref>
###xml 292 299 292 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007514-g004">Fig. 4C</xref>
###xml 372 379 372 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007514-g004">Fig. 4B</xref>
###xml 491 494 491 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lai</italic>
###xml 558 561 558 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lai</italic>
###xml 634 641 634 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007514-g004">Fig. 4A</xref>
###xml 732 736 732 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Morellet1">[38]</xref>
###xml 858 862 858 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Agostini1">[33]</xref>
###xml 864 868 864 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Zhou1">[34]</xref>
Since the G2-arrest activity and apoptosis induction are the most documented effects of Vpr in vitro (reviewed in Refs [1], [36]), Vpr variants were assayed in T lymphocytes for these activities (Fig. 4). Consistent with our previous observations [37], Vpr-induced apoptosis of all variants (Fig. 4C) strictly paralleled the results obtained in the G2-arrest experiments (Fig. 4B). As expected, LTNP-04-2 Vpr, containing the Q65R substitution, failed to induce G2-arrest when compared to VprLai. Similarly, PR-2 and PR-3 variants were less efficient than VprLai. While the lack of activity of PR-3 was due to a problem of expression (Fig. 4A) that might be consequent to the presence of the structurally destabilizing L64P mutation [38], the reduced activity of PR-2 may be related to the S79G substitution, previously shown as deleterious for this activity [33], [34].
###end p 29
###begin title 30
###xml 76 84 <span type="species:ncbi:9606">patients</span>
G2-arrest and pro-apoptotic activities of Vpr proteins from the LTNP and PR patients.
###end title 30
###begin p 31
###xml 89 92 89 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lai</italic>
###xml 152 160 <span type="species:ncbi:9606">patients</span>
HPB-ALL T lymphoid cells were co-transfected with vectors for expression of HA tagged VprLai or the indicated primary Vpr proteins from the LTNP and PR patients, in combination with the GFP expression vector. A) Cellular expression of HA-tagged Vpr proteins. Lysates from HPB-ALL transfected cells were analyzed by western-blotting using anti-GFP and anti-HA antibodies. B) G2-arrest activity of primary Vpr proteins. 48 h after transfection, cells were fixed and the DNA content of GFP-positive cells was analyzed by flow cytometry after DNA staining with propidium iodide. Results are expressed as the G2M/G1 ratios relative to that of the VprLai. C) Pro-apoptotic activity of Vpr proteins. Cells co-expressing the GFP and HA-tagged Vpr proteins were assayed by flow cytometry 72 h following transfection for cell surface phosphatidylserine exposure using AnnexinV coupled to phycoerythrin. Values are means of three independent experiments; error bars represent one standard deviation from the mean.
###end p 31
###begin p 32
###xml 24 30 24 30 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007514-g004">Fig. 4</xref>
###xml 212 216 212 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-deNoronha1">[39]</xref>
###xml 217 221 217 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Waldhuber1">[41]</xref>
###xml 299 303 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Goh1">[18]</xref>
###xml 552 556 552 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Nishizawa1">[40]</xref>
###xml 257 262 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The results reported in Fig. 4 confirm that induction of G2-arrest and apoptosis by Vpr are functionally linked, even if others have suggested that the G2-arrest was not a prerequisite for induction of apoptosis [39]-[41]. Although it was proposed that the HIV-1 LTR was more active in the G2 phase [18], the significance of this cell cycle arrest during infection is still not well understood. Nevertheless, some studies have demonstrated that p24-positive cells isolated from infected individuals have a DNA content that is consistent with G2-arrest [40], indicating that further studies are needed to understand the role of this well-conserved Vpr function in vivo.
###end p 32
###begin p 33
###xml 258 261 258 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lai</italic>
###xml 263 269 263 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007514-g004">Fig. 4</xref>
###xml 351 355 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Lum1">[22]</xref>
###xml 666 673 666 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007514-g005">Fig. 5A</xref>
###xml 951 954 951 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lai</italic>
###xml 1089 1093 1089 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Lum1">[22]</xref>
###xml 1177 1184 1177 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007514-g005">Fig. 5B</xref>
###xml 1222 1226 1222 1226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Lum1">[22]</xref>
###xml 1228 1232 1228 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Mologni1">[23]</xref>
###xml 1300 1303 1300 1303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 1571 1576 1571 1576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NL4-3</italic>
###xml 1613 1617 1613 1617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Andersen2">[37]</xref>
###xml 1619 1623 1619 1623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Lai1">[42]</xref>
###xml 1566 1569 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Interestingly, Vpr variants containing the R77Q substitution, namely LTNP-86 and LTNP-04-1, were even slightly more efficient for G-2 arrest and pro-apoptotic activities than those containing an Arg77, including LTNP-96 and PR-1 as well as the prototypic VprLai (Fig. 4), arguing against a deleterious impact of the R77Q substitution on Vpr functions [22]. To further analyze the influence of the R77Q substitution on the proapoptotic activity of Vpr in the context of the LTNP alleles, we performed a detailed reverse mutational analysis. While the Gln77 found in LTNP-86 and LNTP-04-1 was mutated to Arg, the Arg77 found in LTNP-96 was mutated to Gln. As shown in Fig. 5A, the Q77R substitution of LTNP-86 and LNTP-04-1 resulted in a slightly reduced ability to induce apoptosis, whereas the R77Q LTNP-96 mutant was more active than the parental variant. Furthermore, a similar phenotype was observed when the R77Q substitution was introduced in VprLai. Altogether, these data do not support previous observations on the critical role of Arg77 for the ability of Vpr to induce apoptosis [22]. Similarly, the residue in position 77 had no influence on Vpr-mediated G2-arrest (Fig. 5B). In contradiction with some reports [22], [23], we show that the R77Q substitution, found in the sequence of some vpr alleles from LTNPs, does not abolish the pro-apoptotic activity of Vpr. Instead, our data suggest that this substitution have a null to moderate positive impact on this activity, in agreement with recent reports showing that introduction of the R77Q mutation in HIV-1NL4-3 Vpr results in a functional protein [37], [42].
###end p 33
###begin title 34
Impact of the residue 77 on pro-apoptotic and G2-arrest activities of Vpr LTNP variants.
###end title 34
###begin p 35
###xml 292 300 292 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007514-g004">Figure 4</xref>
The Arg77 residue from VprLai and Vpr LTNP-96 was replaced by a Gln, whereas the Gln residue from LTNP-86 and LTNP-04-1 was replaced by an Arg. The wild-type (grey bars) and mutated (hatched bars) Vpr proteins were then analyzed for apoptosis (A) and G2-arrest (B) activities as described in Figure 4.
###end p 35
###begin p 36
###xml 266 270 266 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Belzile1">[12]</xref>
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Wen1">[17]</xref>
###xml 362 365 362 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lai</italic>
###xml 692 696 692 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-deNoronha1">[39]</xref>
###xml 722 726 722 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Jacquot1">[43]</xref>
###xml 1027 1031 1027 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Vodicka1">[10]</xref>
###xml 1033 1037 1033 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-DiMarzio1">[19]</xref>
###xml 1039 1043 1039 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Chen2">[20]</xref>
###xml 1045 1049 1045 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Mahalingam1">[44]</xref>
One original finding of the present study relies on the identification, in the context of the natural infection, of a Vpr variant harboring the Q65R substitution previously reported as deleterious for DCAF1 binding and consequently for Vpr-induced cell cycle arrest [12]-[17]. Moreover, we now report that this mutation, in both a primary Vpr variant and the VprLai Q65R mutant, abrogates Vpr docking at the NE, raising the possibility of a functional link between Vpr accumulation at the NE and its cytostatic activity. Indeed, it was reported that Vpr expression induced transient ruptures of the NE, resulting in a mixing of cytoplasmic and nuclear components that regulate the cell cycle [39]. As previously discussed [43], Vpr docking at the NE could constitute a prerequisite for binding to DCAF1 and subsequent induction of cell cycle arrest. This hypothesis is strengthened by the observation that almost all Vpr mutants described so far as disrupting the NE accumulation are altered as well for the G2-arrest activity [10], [19], [20], [44]. Alternatively, Vpr binding to DCAF1 might be required for proper docking of Vpr at the NE, where it could then exert its cytostatic activity by means of local interactions.
###end p 36
###begin p 37
###xml 710 718 710 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 927 934 927 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 113 118 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 159 167 <span type="species:ncbi:9606">patients</span>
###xml 283 288 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 599 607 <span type="species:ncbi:9606">patients</span>
###xml 654 659 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1080 1085 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Although no correlation between Vpr functionality of dominant primary alleles and evolution of viral load during HIV-1 infection could be made from two unique patients, this could be achieved through large scale longitudinal studies investigating molecular and functional aspects of HIV-1 Vpr. In the present work, we used this rational approach to revisit, in the context of the natural infection, some aspects of Vpr molecular and functional properties that had been described so far by means of artificially created mutants. Our findings indicate that Vpr variants from either LTNP or progressor patients retain most of the functional features of the HIV-1 Vpr protein previously characterized in different in vitro systems. Most of the primary Vpr proteins displayed efficient cytostatic and pro-apoptotic activities when expressed in T lymphocytes. Although Vpr certainly constitutes an important determinant of virulence in vivo, the real contribution of both cytostatic and cytotoxic properties of the protein to the viral replication and pathogenesis during the course of HIV-1 infection remains unclear. In addition, our results also open new perspectives regarding a possible functional link between Vpr accumulation at the NE and its ability to interact with the DCAF1 subunit of the Cul4a/DDB1 E3 ligase.
###end p 37
###begin title 38
Materials and Methods
###end title 38
###begin title 39
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 15 23 <span type="species:ncbi:9606">Patients</span>
HIV-1 infected Patients
###end title 39
###begin p 40
###xml 57 64 57 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007514-g001">Fig. 1A</xref>
###xml 684 688 684 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Lefrere1">[45]</xref>
###xml 690 694 690 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Lefrere2">[46]</xref>
###xml 1285 1289 1285 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Lefrere1">[45]</xref>
###xml 1291 1295 1291 1295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Lefrere2">[46]</xref>
###xml 71 79 <span type="species:ncbi:9606">patients</span>
###xml 195 200 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 210 217 <span type="species:ncbi:9606">patient</span>
###xml 276 284 <span type="species:ncbi:9606">patients</span>
###xml 340 347 <span type="species:ncbi:9606">patient</span>
###xml 863 870 <span type="species:ncbi:9606">patient</span>
###xml 1060 1067 <span type="species:ncbi:9606">patient</span>
###xml 1276 1284 <span type="species:ncbi:9606">patients</span>
Based on clinical, virological and immunological status (Fig. 1A), two patients with a well-documented natural history of infection (one non-progressor and one progressor) were selected from the HIV-1-infected patient cohort of the St-Antoine Hospital, Paris. These caucasian patients were infected in 1985 with subtype B viruses. The LTNP patient was still asymptomatic 22 years after contamination, in the absence of antiretroviral therapy, with relatively stable CD4 cell counts (>350 cells/mm3) and low levels of viral RNA for the first 10 years of infection. From 2000 to 2006, we observed an increase in the copy number of viral RNA followed by a decrease in the CD4 cell-count [45], [46]. Three samples of frozen peripheral blood mononuclear cells (PBMC) at different time points (1986, 1996, 2004, 2005 and 2006) were analyzed. Conversely, the progressor patient was infected in 1985 and rapidly treated by ZDV on the basis of a low level of CD4+ T lymphocytes (<200 cells/mm3); the PBMC sample analyzed herein was isolated in 1988, 2 years before the patient died of AIDS. All the blood samples were collected in a previous longitudinal study, approved by the ethics committee from the St-Antoine Hospital (Paris, France), with written informed consent from infected patients [45], [46].
###end p 40
###begin title 41
Viral DNA isolation and sequencing
###end title 41
###begin p 42
###xml 192 195 192 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 248 252 248 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Lum1">[22]</xref>
PBMCs were isolated by Ficoll-hypaque density gradient centrifugation, and viral DNA was extracted using QIAamp blood extraction kit (QIAGEN). For each sample, 500 ng DNA were used to amplify vpr genes by two sequential PCR as previously described [22]. The final PCR product was sub-cloned into the pCR3.1 plasmid using the TA Cloning kit (Invitrogen) and subsequently transformed into DH5alpha Max Efficiency bacteria (Invitrogen). At least 40 clones were sequenced.
###end p 42
###begin title 43
Expression vectors
###end title 43
###begin p 44
###xml 12 15 12 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vpr</italic>
###xml 93 96 93 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vpr</italic>
###xml 189 220 189 220 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AGTCGGATCCATGGAACAAGCCCCAGAAGAC</named-content>
###xml 234 265 234 265 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">ACTGCTCGAGTCAGGATCTACTGGCTCCATT</named-content>
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Jacquot1">[43]</xref>
###xml 457 492 457 492 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">FACTGCTCGAGCTATGGAA CAAGCCCCAGAAGAC</named-content>
###xml 515 543 511 539 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">ACTGGGATCCGGATCTACTGGCTCCATT</named-content>
###xml 586 590 582 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Jacquot1">[43]</xref>
###xml 786 789 782 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-LeRouzic2">[9]</xref>
###xml 791 795 787 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Selig2">[47]</xref>
###xml 900 904 896 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-LeRouzic3">[15]</xref>
###xml 409 414 <span type="species:ncbi:4932">yeast</span>
###xml 670 675 <span type="species:ncbi:4932">yeast</span>
###xml 812 817 <span type="species:ncbi:4932">yeast</span>
The primary vpr alleles were subcloned into expression vectors for further characterization. Vpr genes were thus amplified from the pCR3.1 constructs, using the following primers: VprBam-F-AGTCGGATCCATGGAACAAGCCCCAGAAGAC and VprXho-R-ACTGCTCGAGTCAGGATCTACTGGCTCCATT for subcloning into the pLex10 and pAS1B plasmids as previously described [43] , for expression of Vpr as a fusion to LexA or to the HA-tag in yeast and mammalian cells, respectively; VprXho-FACTGCTCGAGCTATGGAA CAAGCCCCAGAAGAC and VprBam-R(DeltaTGA)ACTGGGATCCGGATCTACTGGCTCCATT for subcloning into pEGFP-N3 as described [43] for expression of Vpr as fusions to the N-terminal of the GFP. The vectors for yeast and mammalian expression of hCG1 and UNG2, and the vector for expression of VprR90K were previously described [9], [47]. The vector for yeast expression of DCAF1 was provided by F. Margottin-Goguet (Cochin Institute, Paris) [15]. Site-directed mutagenesis on residue 77 was performed by PCR using specific primers containing the desired mutations.
###end p 44
###begin title 45
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast two-hybrid
###end title 45
###begin p 46
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HIS3</italic>
###xml 193 196 193 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Selig1">[4]</xref>
###xml 198 202 198 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Selig2">[47]</xref>
###xml 8 13 <span type="species:ncbi:4932">yeast</span>
The L40 yeast reporter strain containing the HIS3 LexA-inducible genewas cotransformed with the indicated LexABD and Gal4AD hybrid expression vectors and plated on selective medium as reported [4], [47]. Double transformants were patched on the same medium and replica plated on selective medium lacking histidine for auxotrophy analysis as described.
###end p 46
###begin title 47
Cell culture and transfections
###end title 47
###begin p 48
###xml 84 87 84 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-LeRouzic2">[9]</xref>
###xml 89 93 89 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Py1">[48]</xref>
###xml 255 258 255 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-LeRouzic2">[9]</xref>
###xml 307 311 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Py1">[48]</xref>
HeLa cells and CD4-positive HPB-ALL T-cells were maintained as previously described [9], [48]. HeLa cells were transfected with the Vpr-GFP constructs alone or in combination with Myc-hCG1 expression vector using the calcium phosphate method as described [9]. HPB-ALL cells were electroporated as described [48] with the GFP expression vector as a transfection marker, and the HA-Vpr expression vectors.
###end p 48
###begin title 49
Immunofluorescence
###end title 49
###begin p 50
###xml 110 113 110 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-LeRouzic2">[9]</xref>
###xml 223 226 219 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-LeRouzic2">[9]</xref>
###xml 505 530 501 526 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(Universal Imaging Corp.)</bold>
###xml 280 285 <span type="species:ncbi:10090">mouse</span>
18 h after transfection, HeLa cells were fixed with 4% paraformaldehyde (PFA) and permeabilized as described. [9]. Cells expressing Myc-hCG1 were permeabilized with 55 microg/ml digitonin (Sigma) and then fixed with 4% PFA [9]. Anti-Myc (9E10, Roche) and TexasRed-conjugated anti-mouse IgG (Jackson) were use as primary and secondary antibodies, respectively. Images were acquired with a Leica DMRB epifluorescence microscope equipped with a CCD camera (Princeton) controlled by Metamorph V5.0r6 software (Universal Imaging Corp.).
###end p 50
###begin title 51
Cell cycle and apoptosis
###end title 51
###begin p 52
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Jacquot1">[43]</xref>
###xml 103 107 103 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Py1">[48]</xref>
###xml 449 453 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Jacquot1">[43]</xref>
###xml 455 459 447 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Py1">[48]</xref>
48 h after transfection, half of HPB-ALL cells were collected and fixed with PFA 1% as described [43], [48]. Cells were then permeabilized in cold 70% ethanol and incubated with 200 microg/ml RNAse A and 50 microg/ml propidium iodide. 72 h after transfection, the remaining HPB-ALL cells were analyzed by flow cytometry for cell surface phosphatidylserines (PS) using phycoerythrin-conjugated annexin V (AnnexinV-PE, Bender MedSystems) as described [43], [48]. Cell cycle and PS-exposure profiles were analyzed on GFP-positive cells using a Cytomics FC 500 instrument (Beckman Coulter).
###end p 52
###begin title 53
Protein expression
###end title 53
###begin p 54
###xml 194 198 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007514-Py1">[48]</xref>
###xml 227 232 <span type="species:ncbi:10090">mouse</span>
###xml 272 275 <span type="species:ncbi:10116">rat</span>
###xml 352 357 <span type="species:ncbi:10090">mouse</span>
###xml 367 370 <span type="species:ncbi:10116">rat</span>
HPB-ALL cells expressing HA-Vpr proteins together with GFP were lysed, separated by SDS-PAGE and transferred to a polyvinylidene difluoride (PVDF) Hybond-P membrane (GE Healthcare) as described [48]. Membranes were probed with mouse anti-GFP 7.1-13.1 (1814460, Roche) and rat anti-HA 3F10 (Roche) primary antibodies and with secondary HRP-coupled anti-mouse and anti-rat antibodies (Sigma).
###end p 54
###begin p 55
We thank F. Margottin-Goguet and C. Transy (Cochin Institute, Paris) for the generous gift of reagents, and J. Bouchet for editing of the manuscript.
###end p 55
###begin title 56
References
###end title 56
###begin article-title 57
###xml 21 26 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The Vpr protein from HIV-1: distinct roles along the viral life cycle.
###end article-title 57
###begin article-title 58
Progression to AIDS in the absence of a gene for vpr or vpx.
###end article-title 58
###begin article-title 59
###xml 35 49 <span type="species:ncbi:9544">rhesus monkeys</span>
###xml 55 84 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus.
###end article-title 59
###begin article-title 60
###xml 63 98 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 103 132 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 136 151 <span type="species:ncbi:9531">sooty mangabeys</span>
Uracil DNA glycosylase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunodeficiency virus of sooty mangabeys, but binding does not correlate with cell cycle arrest.
###end article-title 60
###begin article-title 61
###xml 65 100 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 In vivo mutation rate.
###end article-title 61
###begin article-title 62
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Vpr-mediated incorporation of UNG2 into HIV-1 particles is required to modulate thevirus mutation rate and for replication in macrophages.
###end article-title 62
###begin article-title 63
###xml 41 46 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Viral protein R regulates docking of the HIV-1 preintegration complex to the nuclear pore complex.
###end article-title 63
###begin article-title 64
###xml 19 54 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex.
###end article-title 64
###begin article-title 65
###xml 11 16 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Docking of HIV-1 Vpr to the nuclear envelope is mediated by the interaction with the nucleoporin hCG1.
###end article-title 65
###begin article-title 66
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection.
###end article-title 66
###begin article-title 67
###xml 74 79 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
A novel nuclear import of Vpr promoted by importin {alpha} is crucial for HIV-1 replication in macrophages.
###end article-title 67
###begin article-title 68
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpr-Mediated G2 Arrest Involves the DDB1-CUL4A(VPRBP) E3 Ubiquitin Ligase.
###end article-title 68
###begin article-title 69
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system.
###end article-title 69
###begin article-title 70
Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle.
###end article-title 70
###begin article-title 71
###xml 0 4 <span type="species:ncbi:11676?0.7906976744186046">HIV1</span>
HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase.
###end article-title 71
###begin article-title 72
###xml 32 37 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
DDB1 and Cul4A are required for HIV-1 Vpr-induced G2 arrest.
###end article-title 72
###begin article-title 73
###xml 4 8 <span type="species:ncbi:11676?0.7906976744186046">HIV1</span>
The HIV1 protein VPR acts to promote G2 cell cycle arrest by engaging a DDB1 and cullin4A containing ubiquitin ligase complex using VPRBP/DCAF1 as an adaptor.
###end article-title 73
###begin article-title 74
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo.
###end article-title 74
###begin article-title 75
###xml 87 122 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr.
###end article-title 75
###begin article-title 76
###xml 86 99 <span type="species:ncbi:4896">fission yeast</span>
Mutational analysis of Vpr-induced G2 arrest, nuclear localization, and cell death in fission yeast.
###end article-title 76
###begin article-title 77
###xml 22 57 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation.
###end article-title 77
###begin article-title 78
###xml 53 56 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis.
###end article-title 78
###begin article-title 79
###xml 8 13 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 89 94 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 128 136 <span type="species:ncbi:9606">patients</span>
Vpr and HIV-1 disease progression: R77Q mutation is associated with long-term control of HIV-1 infection in different groups of patients.
###end article-title 79
###begin article-title 80
###xml 70 73 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Is the Vpr R77Q mutation associated with long-term non-progression of HIV infection?
###end article-title 80
###begin article-title 81
The APOBEC3 Cytidine Deaminases: An Innate Defensive Network Opposing Exogenous Retroviruses and Endogenous Retroelements.
###end article-title 81
###begin article-title 82
###xml 34 37 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Molecular characterization of the HIV type 1 subtype C accessory genes vif, vpr, and vpu.
###end article-title 82
###begin article-title 83
###xml 22 25 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 41 44 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Replication-competent HIV strains infect HIV controllers despite undetectable viremia (ANRS EP36 study).
###end article-title 83
###begin article-title 84
###xml 48 53 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 94 99 <span type="species:ncbi:9606">human</span>
Effect of R77Q, R77A and R80A changes in Vpr on HIV-1 replication and CD4 T cell depletion in human lymphoid tissue ex vivo.
###end article-title 84
###begin article-title 85
###xml 11 46 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression.
###end article-title 85
###begin article-title 86
###xml 0 28 <span type="species:ncbi:12721">Human immunodeficiency virus</span>
Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition.
###end article-title 86
###begin article-title 87
###xml 22 25 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Immunopathogenesis of HIV infection.
###end article-title 87
###begin article-title 88
###xml 49 52 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants.
###end article-title 88
###begin article-title 89
###xml 33 36 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Phosphorylation of Vpr regulates HIV type 1 nuclear import and macrophage infection.
###end article-title 89
###begin article-title 90
###xml 19 54 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Phosphorylation of human immunodeficiency virus type 1 Vpr regulates cell cycle arrest.
###end article-title 90
###begin article-title 91
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1.
###end article-title 91
###begin article-title 92
###xml 19 24 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The role of Vpr in HIV-1 pathogenesis.
###end article-title 92
###begin article-title 93
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpr-Induced Apoptosis Is Cell Cycle Dependent and Requires Bax but Not ANT.
###end article-title 93
###begin article-title 94
###xml 21 26 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
NMR structure of the HIV-1 regulatory protein VPR.
###end article-title 94
###begin article-title 95
###xml 78 83 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Dynamic disruptions in nuclear envelope architecture and integrity induced by HIV-1 Vpr.
###end article-title 95
###begin article-title 96
###xml 45 80 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Induction of apoptosis by the Vpr protein of human immunodeficiency virus type 1 occurs independently of G(2) arrest of the cell cycle.
###end article-title 96
###begin article-title 97
Studies with GFP-Vpr fusion proteins: induction of apoptosis but ablation of cell-cycle arrest despite nuclear membrane or nuclear localization.
###end article-title 97
###begin article-title 98
###xml 19 24 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The role of Vpr in HIV-1 disease progression is independent of its G2 arrest induction function.
###end article-title 98
###begin article-title 99
###xml 16 21 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Localization of HIV-1 Vpr to the nuclear envelope: Impact on Vpr functions and virus replication in macrophages.
###end article-title 99
###begin article-title 100
###xml 123 158 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr.
###end article-title 100
###begin article-title 101
###xml 19 22 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Non-progression of HIV infection 20 years after diagnosis.
###end article-title 101
###begin article-title 102
###xml 111 139 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection.
###end article-title 102
###begin article-title 103
Interaction with the p6 domain of the gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate lentiviruses.
###end article-title 103
###begin article-title 104
Siva-1 and an alternative splice form lacking the death domain, Siva-2, similarly induce apoptosis in T lymphocytes via a caspase-dependent mitochondrial pathway.
###end article-title 104
###begin p 105
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 105
###begin p 106
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported in part by INSERM, CNRS, Universite Paris-Descartes, the French National Agency for AIDS Research (ANRS), and Sidaction (SB), and by the National Institutes of Health (NIH) research, grant AI49057 (VP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 106

